Search

Cybille Delacroix Muirhei

Examiner (ID: 18979)

Most Active Art Unit
1614
Art Unit(s)
1102, 1614, 1654, 1811
Total Applications
893
Issued Applications
513
Pending Applications
176
Abandoned Applications
204

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4295482 [patent_doc_number] => 06197764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Clozapine compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/978541 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4877 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197764.pdf [firstpage_image] =>[orig_patent_app_number] => 978541 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/978541
Clozapine compositions and uses thereof Nov 25, 1997 Issued
Array ( [id] => 3981564 [patent_doc_number] => 05948886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides' [patent_app_type] => 1 [patent_app_number] => 8/978096 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15389 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948886.pdf [firstpage_image] =>[orig_patent_app_number] => 978096 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/978096
Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides Nov 24, 1997 Issued
08/975551 CYTOKINE REGULATORY AGENTS AND METHODS OF USE IN PATHOLOGIES AND CONDITIONS ASSOCIATED WITH ALTERED CYTOKINE LEVELS Nov 19, 1997 Abandoned
Array ( [id] => 4410396 [patent_doc_number] => 06228858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Advanced glycation end-product intermediaries and post-amadori inhibition' [patent_app_type] => 1 [patent_app_number] => 8/971285 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 85 [patent_no_of_words] => 20459 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228858.pdf [firstpage_image] =>[orig_patent_app_number] => 971285 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/971285
Advanced glycation end-product intermediaries and post-amadori inhibition Nov 16, 1997 Issued
Array ( [id] => 3928844 [patent_doc_number] => 05952502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => '2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole' [patent_app_type] => 1 [patent_app_number] => 8/968780 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6715 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952502.pdf [firstpage_image] =>[orig_patent_app_number] => 968780 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/968780
2R,4S,R, S- and 2S,4R,R,S-hydroxyitraconazole Nov 11, 1997 Issued
Array ( [id] => 4367748 [patent_doc_number] => 06274552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Composition and method for delivery of biologically-active factors' [patent_app_type] => 1 [patent_app_number] => 8/966940 [patent_app_country] => US [patent_app_date] => 1997-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10517 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274552.pdf [firstpage_image] =>[orig_patent_app_number] => 966940 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/966940
Composition and method for delivery of biologically-active factors Nov 9, 1997 Issued
08/945801 PHARMACEUTICAL ADMINISTRATION FORM OF PARATHYROID HORMONE HAVING AN ACTIVE INGREDIENT RELEASE PERIOD OF FROM TWO TO SIX HOURS Nov 9, 1997 Abandoned
Array ( [id] => 4406109 [patent_doc_number] => 06271198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Constrained helical peptides and methods of making same' [patent_app_type] => 1 [patent_app_number] => 8/965056 [patent_app_country] => US [patent_app_date] => 1997-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 40 [patent_no_of_words] => 88868 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 521 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271198.pdf [firstpage_image] =>[orig_patent_app_number] => 965056 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/965056
Constrained helical peptides and methods of making same Nov 4, 1997 Issued
08/793616 USE OF PARACELLULAR ABSORPTION ENHANCERS SUCH AS GLUCOSE FOR ENHAINCING THE ABSORPTION OF HISTAMINE H2-ANTAGONISTS Oct 29, 1997 Abandoned
Array ( [id] => 4237146 [patent_doc_number] => 06165977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Isozyme-specific activators of protein kinase C methods and compositions' [patent_app_type] => 1 [patent_app_number] => 8/953033 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 32 [patent_no_of_words] => 15060 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165977.pdf [firstpage_image] =>[orig_patent_app_number] => 953033 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/953033
Isozyme-specific activators of protein kinase C methods and compositions Oct 16, 1997 Issued
Array ( [id] => 4290728 [patent_doc_number] => 06211335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Method of tissue repair' [patent_app_type] => 1 [patent_app_number] => 8/875228 [patent_app_country] => US [patent_app_date] => 1997-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 6382 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211335.pdf [firstpage_image] =>[orig_patent_app_number] => 875228 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/875228
Method of tissue repair Oct 16, 1997 Issued
Array ( [id] => 4271542 [patent_doc_number] => 06245742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/930616 [patent_app_country] => US [patent_app_date] => 1997-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 16081 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245742.pdf [firstpage_image] =>[orig_patent_app_number] => 930616 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/930616
Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use Oct 14, 1997 Issued
Array ( [id] => 4271446 [patent_doc_number] => 06245736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/949496 [patent_app_country] => US [patent_app_date] => 1997-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5519 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245736.pdf [firstpage_image] =>[orig_patent_app_number] => 949496 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/949496
Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease Oct 13, 1997 Issued
Array ( [id] => 4046718 [patent_doc_number] => 05912328 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Method for the removal of viruses from protein solutions' [patent_app_type] => 1 [patent_app_number] => 8/946024 [patent_app_country] => US [patent_app_date] => 1997-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3353 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912328.pdf [firstpage_image] =>[orig_patent_app_number] => 946024 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/946024
Method for the removal of viruses from protein solutions Oct 6, 1997 Issued
Array ( [id] => 4102615 [patent_doc_number] => 06066716 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Purified heat shock protein complexes' [patent_app_type] => 1 [patent_app_number] => 8/934139 [patent_app_country] => US [patent_app_date] => 1997-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2305 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066716.pdf [firstpage_image] =>[orig_patent_app_number] => 934139 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/934139
Purified heat shock protein complexes Sep 18, 1997 Issued
Array ( [id] => 3926225 [patent_doc_number] => 05945507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Antimicrobial peptides' [patent_app_type] => 1 [patent_app_number] => 8/932682 [patent_app_country] => US [patent_app_date] => 1997-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21321 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945507.pdf [firstpage_image] =>[orig_patent_app_number] => 932682 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/932682
Antimicrobial peptides Sep 17, 1997 Issued
Array ( [id] => 4108895 [patent_doc_number] => 06057294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Peptide' [patent_app_type] => 1 [patent_app_number] => 8/875013 [patent_app_country] => US [patent_app_date] => 1997-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8645 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057294.pdf [firstpage_image] =>[orig_patent_app_number] => 875013 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/875013
Peptide Sep 14, 1997 Issued
Array ( [id] => 3945618 [patent_doc_number] => 05977071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Glucagon-like insulinotropic peptides, compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/927227 [patent_app_country] => US [patent_app_date] => 1997-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6797 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977071.pdf [firstpage_image] =>[orig_patent_app_number] => 927227 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/927227
Glucagon-like insulinotropic peptides, compositions and methods Sep 9, 1997 Issued
Array ( [id] => 3933384 [patent_doc_number] => 05939390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 8/925708 [patent_app_country] => US [patent_app_date] => 1997-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7702 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939390.pdf [firstpage_image] =>[orig_patent_app_number] => 925708 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/925708
Pharmaceutical composition Sep 8, 1997 Issued
Array ( [id] => 4240296 [patent_doc_number] => 06166184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Process for making a bioprosthetic device' [patent_app_type] => 1 [patent_app_number] => 8/912778 [patent_app_country] => US [patent_app_date] => 1997-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11709 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166184.pdf [firstpage_image] =>[orig_patent_app_number] => 912778 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/912778
Process for making a bioprosthetic device Aug 17, 1997 Issued
Menu